127 related articles for article (PubMed ID: 8875485)
1. Molecular methods of enhancing lumbar spine fusion.
Sheehan JP; Kallmes DF; Sheehan JM; Jane JA; Fergus AH; diPierro CG; Simmons NE; Makel DD; Helm GA
Neurosurgery; 1996 Sep; 39(3):548-54. PubMed ID: 8875485
[TBL] [Abstract][Full Text] [Related]
2. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions.
Cook SD; Dalton JE; Tan EH; Whitecloud TS; Rueger DC
Spine (Phila Pa 1976); 1994 Aug; 19(15):1655-63. PubMed ID: 7973957
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
7. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
[TBL] [Abstract][Full Text] [Related]
8. Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers.
David SM; Gruber HE; Meyer RA; Murakami T; Tabor OB; Howard BA; Wozney JM; Hanley EN
Spine (Phila Pa 1976); 1999 Oct; 24(19):1973-9. PubMed ID: 10528370
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
10. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
Schimandle JH; Boden SD; Hutton WC
Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
[TBL] [Abstract][Full Text] [Related]
11. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
[TBL] [Abstract][Full Text] [Related]
12. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract.
Silcox DH; Boden SD; Schimandle JH; Johnson P; Whitesides TE; Hutton WC
Spine (Phila Pa 1976); 1998 Feb; 23(3):291-6; discussion 297. PubMed ID: 9507615
[TBL] [Abstract][Full Text] [Related]
13. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
14. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model.
Sandhu HS; Kanim LE; Kabo JM; Toth JM; Zeegan EN; Liu D; Seeger LL; Dawson EG
Spine (Phila Pa 1976); 1995 Dec; 20(24):2669-82. PubMed ID: 8747245
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic instrumented posterolateral lumbar fusion with Healos and recombinant human growth/differentiation factor-5.
Jahng TA; Fu TS; Cunningham BW; Dmitriev AE; Kim DH
Neurosurgery; 2004 Jan; 54(1):171-80; discussion 180-1. PubMed ID: 14683555
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.
Kanayama M; Hashimoto T; Shigenobu K; Yamane S; Bauer TW; Togawa D
Spine (Phila Pa 1976); 2006 May; 31(10):1067-74. PubMed ID: 16648739
[TBL] [Abstract][Full Text] [Related]
18. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
19. Strut allograft union and remodeling using rhBMP-2 in a spinal corpectomy model.
White KK; Bawa M; Ahn JS; Farnsworth CL; Faro FD; Mahar AT; Wedemeyer M; Garfin SR; Newton PO
Spine (Phila Pa 1976); 2005 Jun; 30(12):1386-95. PubMed ID: 15959367
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
